| Literature DB >> 32677983 |
Zhiping Deng1, Lihua Gong2, Qing Zhang1, Lin Hao1, Yi Ding2, Xiaohui Niu3.
Abstract
BACKGROUND: The clinical and molecular characteristics of osteofibrous dysplasia (OFD)-like adamantinoma (AD) differ from those of classic AD. Most reports about OFD-like AD are case reports or small case series. More cases from different centers are still warranted.Entities:
Keywords: Adamantinoma; Bone sarcoma; Neoplasm; Oncology; Osteofibrous dysplasia-like adamantinoma
Mesh:
Year: 2020 PMID: 32677983 PMCID: PMC7367244 DOI: 10.1186/s13018-020-01769-5
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Representative images of osteofibrous dysplasia-like adamantinoma. Radiographs showing a anterior-posterior and b lateral views of the tumor in the tibial shaft. c CT image showing the extent of the tumor in the cortex. d MRI showing the extent of the tumor
Fig. 2Representative images of classic adamantinoma. Radiographs showing a anterior-posterior and b lateral views of two lesions in the tibial shaft. c CT image showing the extent of the tumor in the cortex. d, e MR images showing the extent of the tumor
Fig. 3Histological images of classic adamantinoma. a Macroscopic section of the specimen in the coronal plane. b, c Hematoxylin-eosin staining (× 200 magnification) and immunohistochemical staining (cytokeratin+)
Fig. 4Histological images of osteofibrous dysplasia-like adamantinoma. a Specimen after curettage. b, c Hematoxylin-eosin staining (× 100 magnification) and immunohistochemical staining (cytokeratin+)
Clinical features, treatment, outcome, and follow-up of seven patients with osteofibrous dysplasia-like adamantinoma
| Patient number | Age gender | Initial localization lesion | Previous surgery | Initial diagnosis | Initial treatment | Surgical margins | Final diagnosis | LR | Other treatment | Outcome | FU months |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 14/M | Tibia, single | None | OFD | Curettage +bone graft | Intralesional | OFD-like AD | CDF | 131 | ||
| 2 | 19/M | Tibia, single | None | OFD-like AD | Resection +Allograft | Wide | OFD-like AD | CDF | 69 | ||
| 3 | 15/M | Tibia and fibula | Curettage | OFD-like AD | Resection +Allograft, fibula resection | Wide | OFD-like AD | CDF | 86 | ||
| 4 | 17/F | Tibia, multiple | Curettage | OFD-like AD | Curettage +cementation | Intralesional | OFD-like AD | 6 months | Curettage +cementation after LR | NED | 65 |
| 5 | 15/F | Tibia and fibula | None | OFD-like AD | Resection +Allograft, fibula resection | Wide | OFD-like AD | 24 months, amputation after allograft infection | CDF | 66 | |
| 6 | 22/F | Tibia, single | None | OFD | Curettage +cementation | Intralesional | OFD-like AD | CDF | 50 | ||
| 7 | 17/F | Tibia,multiple | None | OFD | Curettage +bone graft | Intralesional | OFD-like AD | CDF | 43 |
CDF continued to be disease-free, F female, FU follow-up, LR local recurrence, M male, NED no evidence of disease
Fig. 5Surveillance imaging for osteofibrous dysplasia-like adamantinoma. a. Anterior-posterior and b. lateral views of the tibia at 1 year postoperatively
Clinical features, treatment, outcome, and follow-up of 16 patients with classic adamantinoma
| Patient number | Age gender | Initial localization lesion | Previous surgery | Initial diagnosis | Initial treatment | Surgical margins | Final diagnosis | LR | Distant metastasis | Other treatment | Outcome | FU months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 30/M | Tibia, multiple | None | AD | Resection +Recycled bone | Wide | AD | CDF | 184 | |||
| 2 | 19/F | Tibia and fibula | Curettage | AD | Resection +Allograft, fibular resection | Wide | AD | CDF | 161 | |||
| 3 | 46/M | Tibia, single | Curettage | AD | Resection +Allograft | Wide | AD | CDF | 18 | |||
| 4 | 17/F | Tibia and fibula | None | AD | Resection +Allograft, fibular resection | Wide | AD | CDF | 18 | |||
| 5 | 42/F | Tibia, single | None | AD | Resection +Allograft | Wide | AD | CDF | 175 | |||
| 6 | 27/M | Tibia, single | Curettage | AD | Resection +Allograft | Wide | AD | 84 months | 106 m, lung | Amputation after LR | DOD | 126 |
| 7 | 24/F | Tibia, single | None | AD | Cortical resection + Allograft | Marginal | AD | CDF | 19 | |||
| 8 | 33/M | Tibia, single | None | AD | Cortical resection + Allograft | Marginal | AD | CDF | 97 | |||
| 9 | 23/M | Tibia and fibula | Curettage | OFD | Curettage + Bone grafting | Intralesional | AD | 9 months | Amputation after LR | NED | 142 | |
| 10 | 38/F | Tibia, single | Curettage | AD | Resection +Allograft | Wide | AD | CDF | 125 | |||
| 11 | 33/M | Tibia,multiple | None | AD | Resection +Allograft | Marginal | AD | CDF | 84 | |||
| 12 | 16/F | Fibula, single | None | AD | Resection | Wide | AD | 84 m, new developed tibia lesion resection | NED | 120 | ||
| 13 | 36/M | Tibia,multiple | Curettage | AD | Resection +Allograft | Marginal | AD | 19 months | 20 m, lung | Amputation after LR | DOD | 88 |
| 14 | 20/F | Tibia,multiple | None | AD | Resection +Allograft | Wide | AD | CDF | 84 | |||
| 15 | 18/M | Tibia and fibula | None | AD | BKA | Wide | AD | CDF | 54 | |||
| 16 | 54/F | Tibia, single | Curettage | AD | Resection +Prosthesis | Wide | AD | CDF | 45 |
BKA below the knee amputation, CDF continued to be disease-free, DOD dead of disease, F female, FU follow-up, LR local recurrence, Lung lung metastasis, M male, NED no evidence of disease
Fig. 6Surveillance imaging for classic adamantinoma. a Anterior-posterior and b lateral views of the tibia at 7 years postoperatively
Fig. 7Kaplan-Meier overall survival curve of the 16 patients with classic adamantinoma